R-Tech Ueno to study recombinant human albumin as therapeutic agent for dry eye syndrome

R-Tech Ueno Street Report 3/2012, May 24, 2012

R-Tech Ueno to study recombinant human albumin as therapeutic agent for dry eye syndrome
Scroll to top